Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin for Ureteral Stone Expulsion
NCT01533389Phase 4Completed
- Sponsor
- JW Pharmaceutical Corporation
- Start
- Oct 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of silodosin in ureteral calculus, sponsored by JW Pharmaceutical Corporation. Started Oct 2011; status: completed.
02
Drugs
silodosin
03
Conditions
ureteral calculus
Beyond the preview
Go deeper on NCT01533389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01533389.